Safety and Efficacy of amplitude-modulated radiofrequency electromagnetic fields in advanced hepatocellular carcinoma

" Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide. Despite the recent approval of several new agents, long-term disease control remains elusive for most patients. Administration of 27.12 MHz radiofrequency (RF) electromagnetic fields (EMF) by means of a spoon-shaped antenna (TheraBionic P1 device) placed on the anterior part of the tongue results in systemic delivery of low and safe levels of RF EMF from head to toe." {Credits 1}

" Treatment of advanced HCC with the TheraBionic P1 device is well tolerated, even in patients with severely impaired liver function, and results in improved overall survival compared to historical controls without any significant adverse events, even after many years of continuous treatment." {Credits 1}

{Credits 1} 🎪 Blackstock AW, Benson AB, Kudo M, Jimenez H, Achari PF, et al. 2021. Safety and Efficacy of amplitudemodulated radiofrequency electromagnetic fields in advanced hepatocellular carcinoma. 4open, 4, 3. © 2021 A.W. Blackstock et al. This is an open access article distributed under the terms of the Creative Commons Attribution License.

Last modified on 06-Aug-21

/ EMMIND - Electromagnetic Mind